β-Adrenoceptor-mediated Relaxation of Urinary Bladder Muscle in β2-Adrenoceptor Knockout Mice by Stefan Propping et al.
fphar-07-00118 May 5, 2016 Time: 17:58 # 1
ORIGINAL RESEARCH
published: 09 May 2016
doi: 10.3389/fphar.2016.00118
Edited by:
Paulo Correia-de-Sá,
Universidade do Porto, Portugal
Reviewed by:
James Innes Gillespie,
Newcastle University, UK
Edson Antunes,
State University of Campinas, Brazil
*Correspondence:
Stefan Propping
stefan.propping@uniklinikum-
dresden.de
Specialty section:
This article was submitted to
Cardiovascular and Smooth Muscle
Pharmacology,
a section of the journal
Frontiers in Pharmacology
Received: 16 January 2016
Accepted: 22 April 2016
Published: 09 May 2016
Citation:
ProppingS, LorenzK, MichelMC,
WirthMP andRavensU (2016)
β-Adrenoceptor-mediated Relaxation
of Urinary Bladder Muscle
in β2-Adrenoceptor Knockout Mice.
Front. Pharmacol. 7:118.
doi: 10.3389/fphar.2016.00118
β-Adrenoceptor-mediated Relaxation
of Urinary Bladder Muscle in
β -Adrenoceptor Knockout Mice2
Stefan Propping1,2*, Kristina Lorenz3,4,5, Martin C. Michel6, Manfred P. Wirth1 and
Ursula Ravens2
1 Department of Urology, Faculty of Medicine Carl Gustav Carus, Dresden University of Technology, Dresden, Germany,
2 Department of Physiology, Faculty of Medicine Carl Gustav Carus, Dresden University of Technology, Dresden, Germany,
3 Department of Pharmacology and Toxicology, Julius Maximilian University Würzburg, Würzburg, Germany,
4 Leibniz-Institute für Analytische Wissenschaften-ISAS-e.V., Dortmund, Germany, 5 West German Heart and Vascular Center
Essen, University Hospital Essen-Duisburg, Duisburg, Germany, 6 Department of Pharmacology, Johannes Gutenberg
University, Mainz, Germany
Background and Objective: In order to characterize the β-adrenoceptor (AR)
subtypes involved in agonist-stimulated relaxation of murine urinary bladder we studied
the effects of (−)-isoprenaline and CL 316,243 on tonic contraction and spontaneous
contractions in detrusor strips of wild-type (WT) and β2-AR knockout (β2-AR KO) mice.
Materials and Methods: Urinary bladders were isolated from male WT and β2-AR KO
mice. β-AR subtype expression was determined with quantitative real-time PCR. Intact
muscle strips pre-contracted with KCl (40 mM) were exposed to cumulatively increasing
concentrations of (−)-isoprenaline or β3-AR agonist CL 316,243 in the presence and
absence of the subtype-selective β-AR blockers CGP 20712A (β1-ARs), ICI 118,551
(β2-ARs), and L748,337 (β3-ARs).
Results: Quantitative real-time PCR confirmed lack of β2-AR expression in bladder
tissue from β2-AR KO mice. In isolated detrusor strips, pre-contraction with KCl
increased basal tone and enhanced spontaneous activity significantly more in β2-AR KO
than in WT. (−)-Isoprenaline relaxed tonic tension and attenuated spontaneous activity
with similar potency, but the concentrations required were two orders of magnitude
higher in β2-AR KO than WT. The concentration-response curves (CRCs) for relaxation
were not affected by CGP 20712A (300 nM), but were shifted to the right by ICI 118,551
(50 nM) and L748,337 (10 µM). The −logEC50 values for (−)-isoprenaline in WT and β2-
AR KO tissue were 7.98 and 6.00, respectively, suggesting a large receptor reserve of
β2-AR. (−)-CL 316,243 relaxed detrusor and attenuated spontaneous contractions from
WT and β2-AR KO mice with a potency corresponding to the drug’s affinity for β3-AR.
L743,337 shifted the CRCs to the right.
Conclusion: Our findings in β2-AR KO mice suggest that there is a large receptor
reserve for β2-AR in WT mice so that this β-AR subtype will mediate relaxation of tone
and attenuation of spontaneous activity under physiological conditions. Nevertheless,
upon removal of this reserve, β3-AR can also mediate murine detrusor relaxation.
Keywords: detrusor muscle, relaxation, mucosa, β2-adrenoceptor knockout, β3-adrenoceptors, isoprenaline,
CL 316,243
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INTRODUCTION
Standard therapy of overactive bladder syndrome consists
of muscarinic receptor antagonists, but β3-AR agonists
have recently been introduced as a promising alternative
(Chapple et al., 2014). Experimental studies of β-AR-mediated
relaxation in isolated detrusor strips are complicated by species
differences. While such relaxation of human detrusor is mediated
predominantly if not exclusively by the β3-AR (for reference,
see Wuest et al., 2009), most studies in rats have reported
an involvement of both β2- and β3-AR (Takeda et al., 2003;
Uchida et al., 2005). Subtypes involved in mouse bladder are
controversial. While we have found that detrusor relaxation is
mediated via β2-AR (Wuest et al., 2009; Propping et al., 2015a),
other authors have suggested β3-ARs as the relevant subtype
(Deba et al., 2009). Some of this discrepancy may be due to
different experimental conditions, but another major issue is that
the various drugs employed may actually not exhibit the assumed
β-AR subtype selectivity (Cernecka et al., 2014).
Irrespective of the debate on β-AR subtypes involved in
detrusor relaxation in various species, it has been questioned
whether a direct effect on detrusor smooth muscle cell tone
indeed is the underlying cellular mechanism for in vivo inhibition
of detrusor overactivity by β-AR agonists (Eastham et al.,
2015). This is based on the observation that concentrations
of β3-AR agonists as for instance mirabegron to induce
human detrusor strip relaxation are considerably higher (EC50
∼1.7 µM, Svalo et al., 2013) than the plasma concentrations
at therapeutic doses (30–75 nM, Krauwinkel et al., 2012).
There is some evidence, that modulation of spontaneous
contractions could represent an alternative target for the
therapeutic effect of β3-AR agonists in overactive bladder
syndrome. Pre-contracting isolated detrusor tissue with KCl
or muscarinic agonists not only increases tonic tension but
also induces irregular force oscillations of variable amplitude
and frequency (spontaneous contractions, also referred to as
“phasic contractions” or “microcontractions”; Gillespie et al.,
2015a) Interestingly, spontaneous contractions of detrusor in
rats are more sensitive to suppression by (−)-isoprenaline than
nerve-mediated contractions evoked by electric field stimulation,
but this may be mediated via β1-AR (Gillespie et al., 2015b).
β-AR subtypes mediating inhibition of spontaneous contractions
in other species including mice have not been explored in a
systematic manner.
Therefore, we have examined which β-AR subtype
mediates inhibition of murine detrusor tone and spontaneous
contractions. To address this, we have used the general β-AR
agonist (−)-isoprenaline and the β3-AR agonist CL 316,243 in
Abbreviations: β-AR, β-adrenoceptor; β2-AR KO, β-2-adrenoceptor knockout;
CGP 20712A, 1-[2-((3-carbamoyl-4-hydroxy)phenoxy)ethylamino]-3-[4-(1-
methyl-4-trifluoromethyl-2-imidazolyl)phenoxy]-2-propanol; CL 316,243, (R,R)
-5-[2-[[2-(3-chlorophenyl)-2-hydroxy-ethyl]-amino]propyl]-1,3-benzodioxole-
2,2-dicarboxylate; CRC, concentration response curve; ICI 118,551, (±)-1-[2,3-
(dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-2-butanol;
(−)-isoprenaline, 4-[1-hydroxy-2-[(1-methylethyl)amino] ethyl]-1,2-benzenediol
hydro-chloride; L748,337, (S)-N-[4-[2-[3-[3-(acetamidomethyl) phenoxy]-
2-hydroxypropyl]-amino]-ethyl]-phenylbenzsulfonamide); RT-PCR, reverse
transcription polymerase chain reaction.
KCl-precontracted strips of β2-AR knockout (β2-AR KO) mice
and their wild-type (WT) controls with separate analysis of
detrusor tone and spontaneous contractions. Our results confirm
the importance of β2-ARs for murine detrusor relaxation
and attenuation of spontaneous contractions, but also attest
contribution of β3-ARs.
MATERIALS AND METHODS
The control experiments of the present study were performed
in FVB/N-WT mice, which match the genetic background
of β2-AR KO mice. The mice were bred in the Department
of Pharmacology and Toxicology, University of Würzburg,
Germany. All experiments were performed in accordance
with the local authorities (permission number 24D-9168.24-
1/2007-17 of the Regierungspräsidium Dresden and of
the Regierung of Unterfranken permission number 55.2-
2531.01-60/13, Germany) and comply with the European
Commission Directive 86/609/EEC regarding the protection and
welfare of animals used for experimental as well as scientific
purposes.
Determination of β-AR Subtypes
Expression in Mouse Detrusor
Male FVB/N-WT controls and β2-AR KO mice (24–40 weeks)
were killed by cervical dislocation under CO2 anesthesia, and
urinary bladders and lungs were removed. The bladders were
cut open and detrusor tissue and mucosa were dissected with
sharp scissors and further processed separately. RNA was isolated
from the tissue samples using the RNeasy R©-Kit (Qiagen) and
total RNA was reverse transcribed using Superscript II reverse
transcriptase (Invitrogen). For cDNA amplification of β1-ARs,
β2-ARs, β3-ARs and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH), a reaction mixture was used containing SsoFast
EvaGreen Supermix (BioRad). Quantitative real-time PCR was
performed using the C1000 Thermal Cycler CFX96 (BioRad) and
the data was analyzed as previously described (Vidal et al., 2012).
Amplification conditions for RT-PCR were 15 s at 95◦C followed
by five cycles of 30 s at 94◦C, 30 s at 60◦C (for Adrb2 at 64◦C)
and 30 s at 72◦C, five cycles of 30 s at 94◦C, 30 s at 62◦C
and 30 s at 72◦C and 25 cycles of 30 s at 94◦C, 30 s at
64◦C and 30 s at 72◦C and an additional cycle of 15 s at
80◦C. The following primers were used (Evans et al., 1999;
Chernogubova et al., 2005; Wuest et al., 2009; Vidal et al.,
2012):
GAPDH forward primer 5′-TGGCAAAGTGGAGATTG
TTG-3′;
GAPDH reverse primer 5′-CATTATCGGCCTTGACTG
TG-3′;
β1-AR forward primer 5′-CCGCTGCTACCACGACCC
CAAG-3′;
β1-AR reverse primer 5′-AGCCAGTTGAAGAAGAG
CAAGAGGCG-3′;
β2-AR forward primer 5′-GGTTATCGTCCTGGCCAT
CGTGTTTG-3′;
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β2-AR reverse primer 5′-TGGTTCGTGAAGAAGTCA
CAGCAAGTCTC-3′;
β3-AR forward primer 5′-TCTAGTTCCCAGCGGAGTT
TTCATCG-3′;
β3-AR reverse primer 5′-CGCGCACCTTCATAGCCAT
CAAACC-3′.
Experimental Procedure for Measureing
Detrusors Contractions and Relaxations
Characterization of mice: the WT and β2-AR KO mice had
average body weights of 29 ± 3 g for WT (n = 55) and 28 ± 4 g
for β2-AR KO mice (n = 49). Strips of mouse urinary bladder
were dissected as described previously (Propping et al., 2015a,b).
Muscle strips with an intact mucosal layer (mean weight WT
mice 2.9 ± 1.6 mg, n = 75 strips; β2-AR KO mice 2.4 ± 1.8 mg,
n = 74, P = 0.26) were mounted in an organ bath filled with
5 ml of modified Tyrode solution of the following composition
(in mM): NaCl 126.9, KCl 5.4, MgCl2 1.05, CaCl2 1.8, NaH2HPO4
0.45, NaHCO3 22, EDTA 0.04, ascorbic acid 0.2, glucose 5.6.
Phentolamine (3 µM) and prazosin (1 µM) were added to block
α-ARs. The solution in the bath was maintained at 37◦C, and
was oxygenated by vigorously bubbling with carbogen (95% O2,
5% CO2). The pH was 7.4. All drugs were obtained from the
same sources and dissolved either in distilled water of dimethyl
sulfoxide as in our previous study (Propping et al., 2015c). The
DMSO concentration in the bath did not exceed 0.3%.
The detrusor strips were connected to an isometric force
transducer (GM2; Föhr Medical Instruments, Seeheim/Ober-
Beerbach Germany) and preloaded with 5 mN. After 30 min
in the organ bath, tension was readjusted to 5 mN. Force of
contraction was recorded with Chart 4.0TM (AD Instruments,
Sydney, NSW, Australia). Tonic tension was analyzed as the
increase of force produced by 40 mM KCl, measured from the
lower limit of the “noise” produced by spontaneous activity
under baseline conditions and in the presence of KCl. The
amplitudes and the time integral of spontaneous contractions
were analyzed during the 2-min period before the next
concentration increase, using Chart software. Agonist-induced
attenuation of spontaneous activity was expressed as integral in
percent of control.
The preparations were allowed to equilibrate for at least
60 min. During this period, they were stimulated two consecutive
times with KCl (40 mM, without osmotic compensation). After
another 45 min of washout, the strips were pre-contracted by
depolarization with 40 mM KCl. Relaxation was induced with
cumulatively increasing concentrations of (−)-isoprenaline, CL
316,243 or forskolin. Relaxation was measured as the difference
between minimum force prior to addition of agonist (steady state
force) and force in the presence of the agonist, and was expressed
in percent of the response to 10 µM forskolin added at the end of
each experiment (= 100%). All β-AR subtype-selective blockers
were added 30 min before the start of KCl pre-contraction and
remained in the bath solution throughout the remainder of the
experiment. The concentrations of antagonists were CGP 20712A
300 nM, ICI 118,551 50 nM (Wuest et al., 2009; Propping et al.,
2015a), and L748,337 100 nM to 10 µM (Deba et al., 2009).
FIGURE 1 | Expression of β-AR subtypes in urinary bladders und lungs
of WT and β2-AR knockout mice. (A) Agarose gel electrophoresis of
qualitative PCR of cDNA obtained from urinary bladder detrusor samples (left
panel) and lung samples (right panel) of WT and β2-AR KO mice for β1-AR,
β2-AR, β3-AR and glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
(B) mRNA expression of β1-AR, β2-AR, and β3-AR normalized to GAPDH in
detrusor (WT, n = 3; β2-AR KO, n = 5). n represent numbers of mice
measured in triplicates. Mean values ± SD.
Calculation of −logEC50 Values
Concentration-response curves were constructed by non-
linear regression for each individual experiment by using
Prism 5.0 R©(GraphPad R©Software, Inc., San Diego, CA, USA). The
negative logarithm to the base of 10 of the molar concentration
producing 50% of the maximum response (−logEC50 [M]) as well
as the maximum response (Emax) were calculated and expressed
as mean ± SD. Please note that the non-linear regression curves
depicted in the figures were fitted to the mean values of the data.
In Schild plots, log(CR-1) was plotted versus log(molar
concentration of antagonist), where CR stands for concentration
ratio, i.e., the agonist concentration producing 50% of the
maximum effect (EC50) in the presence of the antagonist divided
by the EC50 of in the absence of antagonist (Schild, 1947).
The pA2 value as a measure of potency of a surmountable
antagonist was extrapolated from a straight line with the slope
of unity, given by the formula
pA2 = log(CR− 1) − log(antagonist concentration).
The same formula was used for calculating the apparent
pA2 values by substituting the experimental values for one
concentration only.
Statistical Analysis
The results are represented as mean ± standard deviation
(mean ± SD). A two-tailed t-test for unequal samples with
different variances was used for two-group comparisons and
was calculated with Prism 5.0 R©(GraphPad R©Software, Inc., San
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FIGURE 2 | Relaxation of KCl-precontracted intact detrusor strips from WT and β2-AR KO mice. (A) Original tracings of force of contraction (in mN) from
two intact detrusor strips precontracted with KCl (40 mM) and subsequently relaxed with cumulatively increasing concentrations of (−)-isoprenaline. Forskolin
(10 µM) was added at the end of each experiment. (B) Baseline amplitude (upper panel) and baseline integral (lower panel) of spontaneous activity before, and
amplitudes and integrals after addition of KCl. (C) CRCs for the relaxing effects of (−)-isoprenaline on KCl-induced tone in detrusor strips from WT (open symbols)
and β2-AR KO (closed symbols). Since tonic contraction was completely relaxed with 10 µM forskolin, the CRCs were normalized to the response with forskolin (=
100%). (D) CRCs for spontaneous activity expressed as force-time integral in percent of pre-agonist control for WT (open symbols) and β2-AR KO (closed symbols).
A quantitative analysis of the data is shown in Table 1.
Diego, CA, USA). Analysis of variance (ANOVA) was used for
multiple group comparison, followed by an additional Bonferroni
comparison test where appropriate. P < 0.05 was regarded as
significant.
RESULTS
Expression of β-AR Subtypes in Intact
Murine Detrusor Muscle
Expression of the three β-AR subtypes was determined by RT-
PCR and quantitative real-time PCR in intact detrusor tissue
from WT and genetically modified animals in order to verify
knock-out of β2-ARs and to check for any compensatory changes
in expression of β1- and β3-ARs. Figure 1 shows that β2-ARs
were only detectable in detrusor tissue from WT but not from
β2-AR KO mice, and the same results were obtained in the
respective lung tissues, which served as controls. Furthermore,
β1- and β3-ARs were expressed in bladder and lung tissue from
all animals (Figure 1A). Between WT and β2-AR KO mice
there were no differences in expression levels of β1- and β3-ARs
(Figure 1B).
Baseline and KCl-induced Detrusor
Contractions in WT and β2-AR KO Mice
Depolarization of mouse detrusor strips with 40 mM KCl
induced a rapid increase in tone and spontaneous activity,
which stabilized within 45 min (Figure 2A). Mean values of
peak force (Fpeak) increases were greater in strips from β2-
AR KO (2.86 ± 1.34 mN/mg w.w., n = 7/7) than WT mice
(1.42 ± 0.97 mN/mg w.w., n = 18/14; P < 0.05); steady-
state tone (Fss) was 1.57 ± 0.76 mN/mg w.w. β2-AR KO and
0.76± 0.28 mN/mg w.w. in WT (P < 0.05).
In the same detrusor strips the baseline amplitudes of
spontaneous contractions and their time integrals were greater in
β2-AR KO than in WT mice [amplitudes: 0.46 ± 0.34 mN/mg
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FIGURE 3 | Effects β-AR blockers on detrusor tone and time-integral of spontaneous activity after exposure to 40 mM KCl (CGP, 300 nM CGP
20712A; ICI, 50 nM ICI 118,551; L748,337, 100 nM L748,337). (A,B) Peak increase (Fpeak) and steady-state increase in tone (Fss), respectively, after exposure to
40 mM KCl from WT and β2-AR KO preparations. Please note the difference in scale. (C,D) Time-integral of spontaneous contractions from WT and β2-AR KO
preparations; baseline time-integral before (C) and time-integral after (D) exposure to 40 mM KCl. Mean ± SD from number of experiments as indicated. ∗denotes
P < 0.05 compared with control.
w.w. and 0.16 ± 0.13 mN/mg w.w., P < 0.05; integral:
18.34± 10.51 (mN/mg w.w.)∗s, and 6.26± 3.74 (mN/mg w.w.)∗s,
P < 0.05]. After addition of KCl the integral for spontaneous
detrusor activity increased significantly to 41.60± 39.78 (mN/mg
w.w.)∗s in β2-AR KO and to 10.30± 8.77 (mN/mg w.w.)∗s in WT
(P < 0.05; Figure 2B).
The β1-AR blocker CGP 20712A (300 nM) had little effect
on KCl-induced Fpeak and Fss in either mouse strain (Figure 3),
except for Fss in WT mice (Figure 3B). CGP 20712A did not affect
spontaneous contraction integral neither at baseline nor after
KCl (Figures 3C,D). Exposure to the β2-AR blocker ICI 118,551
(50 nM) increased Fpeak and baseline spontaneous activity in
strips from β2-AR KO mice. Responses to the β3-AR blocker
L748,337 (100 nM) exhibited great variability, but appeared to
increase Fpeak and Fss rather than spontaneous activity.
(−)-Isoprenaline-induced Detrusor
Relaxation in WT and β2-AR KO Mice
Increasing concentrations of (−)-isoprenaline caused almost
complete relaxation of tone, and attenuation of spontaneous
activity in intact strips from WT and β2-AR KO mice
(Figures 2C,D). However, strips from β2-AR KO mice were
significantly less sensitive by almost 2 log units. The −logEC50
values for (−)-isoprenaline-induced relaxation of tone were 7.98
for WT and 6.00 for β2-AR KO mice (see Table 1). The respective
values for the (−)-isoprenaline-induced attenuation of integral
for spontaneous contractions were 8.39 ± 1.06 and 6.34 ± 0.63,
and were not significantly different from the effect on relaxation
of tone.
In detrusor strips from WT mice, CGP 20712A (300 nM)
and L748,337 (100 nM) had little effect on the CRCs of (−)-
isoprenaline, whereas the β2-AR blocker ICI 118,551 (50 nM)
shifted the CRCs to higher (−)-isoprenaline concentrations by
about 1.4 log units (Figure 4, top panels). In β2-AR KO mice,
the three β-AR blockers produced little effect on the CRCs
of (−)-isoprenaline (Figures 4A–C), and the small shift to
the right with 100 nM L748,337 did not reach significance.
All −logEC50 and Emax values are summarized in Table 1.
Spontaneous activity was attenuated by (−)-isoprenaline to
a somewhat larger extent in β2-AR KO than WT strips
(Figures 4D–F). The effects of (−)-isoprenaline on spontaneous
activity were not influenced by blocking β1-AR with CGP
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TABLE 1 | Relaxing effects of (−)-isoprenaline, CL 316,243 and forskolin in murine detrusor strips and their modulation by selective β-AR antagonists.
Mouse strain Relaxing agent β-AR antagonist −logEC50 [M] Emax [%] n
WT (−)-Isoprenaline None (control) 7.98 ± 0.12 83 ± 2 18/14
300 nM CGP 20712A 7.89 ± 0.14 88 ± 4 5/4
50 nM ICI 118,551 6.63 ± 0.15∗ 96 ± 5∗ 6/6
100 nM L748,337 8.06 ± 0.16 88 ± 4 5/5
1 µM L748,337 7.70 ± 0.50 83 ± 7 4/4
3 µM L748,337 7.73 ± 0.25 88 ± 2 6/6
10 µM L748,337 6.49 ± 0.29∗ 87 ± 3∗ 5/5
β2-AR KO (−)-Isoprenaline None (control) 6.00 ± 0.14 94 ± 4 7/7
300 nM CGP 20712A 5.93 ± 0.11 99 ± 8 6/6
50 nM ICI 118,551 5.94 ± 0.13 94 ± 5 5/5
100 nM L748,337 5.74 ± 0.09 94 ± 2 9/9
WT CL 316,243 None (control) 6.76 ± 0.29 64 ± 12 6/6
1 µM L748,337 6.02 ± 0.30∗ 73 ± 9 9/7
3 µM L748,337 6.40 ± 0.42 90 ± 5∗ 3/3
10 µM L748,337 6.17 ± 0.22∗ 93 ± 2∗ 4/4
β2-AR KO CL 316,243 None (control) 6.94 ± 0.64 67 ± 16 7/7
100 nM L748,337 6.44 ± 0.45 66 ± 11 8/8
300 nM L748,337 6.32 ± 0.74 65 ± 13 7/7
1 µM L748,337 6.07 ± 0.54 69 ± 10 4/4
3 µM L748,337 6.25 ± 0.44 87 ± 14 7/7
10 µM L748,337 6.27 ± 0.58 92 ± 6∗ 8/8
WT Forskolin None (control) 6.63 ± 0.54 – 4/4
β2-AR KO Forskolin None (control) 6.14 ± 0.24 – 6/6
Comparison with respective control without any blocker: ∗P < 0.05. Pre-contraction by 40 mM KCl. −logEC50, negative logarithm of the concentration of agonist required
for half-maximum relaxation in the absence or presence of extra drug; Emax, maximum response to agonist expressed in percent of the response to 10 µM forskolin (=
100%); n, number of detrusor strips in number of mice.
20712A (Figure 4D). There was a trend for a shift in the CRC
by the β2-AR blocker ICI 118,551 in WT strips (Figure 4E)
and by the β3-AR blocker L748,337 in β2-AR KO strips
(Figure 4F). Again, due to the large variability, the effects
on spontaneous contractions were less clear than on tonic
contraction.
These findings confirm our previous observations (Wuest
et al., 2009; Propping et al., 2013, 2015a) that β2-ARs are
the major β-AR subtype mediating relaxation in WT detrusor
strips. However, given the low affinity of L748,337 for murine
β3-ARs (Cernecka et al., 2014), the concentration of 100 nM
L748,337 may not have been sufficient to block murine β3-
AR. Therefore, higher L748,337 concentrations were employed
to antagonize (−)-isoprenaline-mediated relaxation in WT
detrusor (Figure 5). With 10 µM L478,337, the CRC was
clearly shifted to the right (Figure 5C). The results with
1 and 3 µM L748,557 were less consistent (Figures 5A,B).
Nevertheless, these findings suggest that β3-ARs may be
involved to a larger extent than previously anticipated by us
(Propping et al., 2015a), but as suggested by Deba et al.
(2009). The Schild plot (Figure 5D) clearly deviated from unity
suggesting a more complex mechanism than simple competition
of (−)-isoprenaline and L748,337 for a single binding site.
Fitting a linear regression of slope 1 to the data points,
yielded a pA2 value of 6.08 for L748,337 in strips from WT
mice.
CL 316,243-Induced Detrusor Relaxation
in WT and β2-AR KO Mice
In order to resolve these different interpretations, we next
investigated the effects of the β3-AR-selective agonist CL
316,243 that was employed by Deba et al. (2009). Increasing
concentrations of CL 316,243 relaxed detrusor strips from WT
and β2-AR KO with similar potency and efficacy (Figure 6).
In comparison with (−)-isoprenaline, CL 316,243 tended to be
less potent in strips from WT than β2-AR KO mice (compare
Figure 2, Table 1). Again, more vigorous spontaneous activity
was observed in β2-AR KO than WT strips (Figure 6B).
The complete CRCs revealed that detrusor strips relaxed less
completely (Figure 6C, Table 1) and that attenuation of
spontaneous activity failed to reach significance both in WT
and β2-AR KO strips (Figure 6D). Concentrations of 100–
300 nM L748,337 had no significant effect on the CRCs for CL
316,243 under any experimental condition, but concentrations
between 1 and 10 µM L748,337 induced complex changes in
relaxation (Figures 7A,B). In strips from WT mice, L748,337
did not shift the CRCs of CL 316,243, but with 3 and
10 µM L748,337 relaxation became more complete. In β2-AR
KO mice, L748,337 caused a shift of the CRCs to higher
concentrations of CL 316,243, in addition to more complete
relaxation. Again, the Schild plot (Figure 7C) deviated from unity
indicating a complex mechanism of interaction also between
CL 316,243 and L748,337. Using a slope factor of 1, the
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FIGURE 4 | Effects of various β-AR subtype selective blockers on CRCs for (−)-isoprenaline-induced relaxation of KCl-induced tone (A–C) and
spontaneous contractions (D–F) in detrusor strips from WT (open symbols) and β2-AR KO mice (closed symbols). CRCs were performed in the presence
of the β1-AR-selective blocker CGP 20712A (A,D), the β2-AR-selective blocker ICI 118,551 (B,E), the β3-AR-selective blocker L748,337 (C,F). The respective
controls (WT, dashed gray lines; β2-AR KO, continuous gray lines) were taken from the same experiments as in Figure 2. Mean values ± SD from n experiments as
indicated in parenthesis (number of strips/number of animals).
pA2 value was 6.70 for L748,337 in strips from β2-AR KO
mice.
β-AR-independent Detrusor Relaxation
by Forskolin in WT and β2-AR KO Mice
In order to estimate receptor-independent relaxation we have also
studied the responses to adenylyl cyclase activation with forskolin
(Morita et al., 1986) in WT and β2-AR KO mice (Figure 8).
Forskolin completely relaxed tonic tension (Figure 8A) and
attenuated spontaneous contractions (Figure 8B) and there were
no differences in sensitivity between strips from WT and β2-AR
KO mice (Table 1).
DISCUSSION
The aim of the present study was to investigate the β-AR subtypes
involved in attenuating tonic and spontaneous contraction of
murine detrusor in order to elucidate the discrepancy between
our own results (Wuest et al., 2009; Propping et al., 2015a) and
those of others (Deba et al., 2009) by utilizing β2-AR KO mice and
β-AR subtype-selective ligands as pharmacological tools (Schmid
et al., 2015).
Regulation of detrusor contractility is complex and not
fully understood. The central force-developing step in detrusor
contraction is the interaction between myosin and actin
filaments that occurs upon phosphorylation of myosin light
chains (MLC) via Ca2+-calmodulin dependent MLC kinase
(MLCK, Andersson and Arner, 2004; Hashitani et al., 2004).
Several signal transduction pathways are likely to be involved
in β-AR-mediated smooth muscle relaxation. The canonical
signaling pathway for β-AR involves stimulation of adenylyl
cyclase, elevation of cellular cAMP levels and activation of
protein kinase A (PKA). Activated PKA phosphorylates MLCK
thereby impairing its Ca2+-calmodulin-dependent activation,
which reduces MLC phosphorylation and hence muscle tone
(Andersson and Arner, 2004; Hashitani et al., 2004). β-AR-
mediated relaxation also involves Ca2+-activated K+ channels
of large conductance (BKCa channels; Petkov, 2014). Enhanced
BKCa channel activity via PKA-mediated phosphorylation may
contribute to relaxation by hyperpolarizing the cell membrane
and reducing Ca2+ influx via voltage-dependent Ca2+ channels
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FIGURE 5 | Effects of the β3-AR-selective blocker L748,337, 1 µM (A), 3 µM (B), and 10 µM (C), on CRCs for (−)-isoprenaline-induced relaxation of
KCl-precontracted detrusor strips from WT mice. The control is taken from the same experiments as in Figure 2. Mean values ± SD from n experiments as
indicated in parenthesis (number of strips/number of animals). (D) Schild plot for determining the pA2 value of L748,337 (see Materials and Methods for further
details).
(Wegener et al., 2004). However, Frazier et al. (2005) questioned
the role of cAMP in β-AR-mediated relaxation because inhibitors
of adenylyl cyclase or PKA had limited effect on rat detrusor
relaxation, suggesting that other unknown pathways are involved
as well.
Which β-AR Subtype Mediates
(−)-Isoprenaline- or CL 316,243-induced
Murine Detrusor Relaxation?
Constitutive systemic knockout of a particular receptor subtype
may cause compensatory changes in expression of other receptors
or proteins (Michel and Seifert, 2015). Therefore, the expression
of all β-AR subtypes in detrusor tissue from WT and transgenic
mice was checked using RT- PCR and quantitative real-time
PCR. Despite cumulating evidence that GAPDH expression
is decreased under conditions of increased sympathetic tone
(Michel-Reher and Michel, 2015) we normalized the expression
data to GAPDH as a housekeeping gene. In real-time PCR
GAPDH remained constant (data not shown) so that we felt safe
with this normalization. Our results clearly indicated complete
absence of the β2-AR subtype, whilst compensatory expression of
β3-(or β1-)ARs is absent in detrusor tissue from β2-AR KO mice.
Since the β2-AR KO mice were bred against a genetic
background different from the previously used C57Bl6 mice,
new control experiments had to be performed with FVB/N-
WT mice. The results were similar as in C57Bl6 mice (Wuest
et al., 2009; Propping et al., 2015a), i.e., the β2-AR blocker ICI
118,557 significantly shifted the CRCs for (−)-isoprenaline to the
right, confirming that β2-ARs are involved in this relaxing effect.
The affinity estimate calculated for ICI 118,557 based on these
shifts (apparent pA2 values: 8.63) was in good agreement with its
known affinity at β2-AR (for instance 8.92 and 8.8 for human β2-
AR expressed in CHO cells, respectively, Tate et al., 1991; Palea
et al., 2012).
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FIGURE 6 | Relaxation in response to the β3-AR-selective agonist CL 316.243 of KCl-pre-contracted detrusor strips from wild type (WT) and β2-AR
KO mice. (A) Original tracings of force of contraction (in mN) from two detrusor strips precontracted with KCl (40 mM) and subsequently relaxed with cumulatively
increasing concentrations of CL 316,243. At the end of each experiment complete relaxation was induced with forskolin (10 µM) as indicated. (B) Amplitude (upper
panel) and integral (lower panel) of spontaneous activity before and after addition of KCl. (C,D) CRCs for the CL 316,243 effects on tone and spontaneous activity in
WT and β2-AR KO, respectively. Similar lay-out as in Figure 2.
In the absence of any β2-ARs in the KO animals, the detrusor
relaxation response to (−)-isoprenaline could be mediated by
β1- or β3-AR. Since β1-ARs are predominant only in guinea-
pig urinary bladder (Yamamoto et al., 1998), the relaxant
effect of (−)-isoprenaline in the β2-AR KO mice must have
been mediated via β3-ARs. The (−)-isoprenaline concentrations
required for half-maximum relaxation were about ∼90-fold
higher in detrusor from β2-AR KO than WT mice. Given the
affinity of murine β3-ARs for (−)-isoprenaline, e.g., −logEC50
5.57 (Blin et al., 1994), this is indeed in the concentration range
required for β3-AR activation. Furthermore, the selective β3-AR
agonist CL 316,243 clearly produced relaxation in detrusor strips
both from WT and β2-AR KO mice with similar−logEC50 values
which corresponded to the−logEC50 value of 8.61 for CL 316,243
at rodent β3-AR (Clouse et al., 2007).
The −logEC50 value of (−)-isoprenaline for relaxation of WT
mouse detrusor, i.e., 7.98 was about 1.5 orders of magnitude lower
than its known affinity at mammalian β2-AR (pKi 6.4; www.guid
etopharmacology.org). This finding suggests that there is a large
receptor reserve for detrusor relaxation via β2-AR. When β2-
AR are blocked with ICI 118,551 or are absent as in β2-AR KO
mice, (−)-isoprenaline is able to relax mouse detrusor via β3-AR
stimulation, but spare receptors do not appear to play a role in
this case.
Although, small molecule inhibitors have been valuable tools
to characterize receptor subtypes in pharmacological studies,
the interpretation of such results is complicated because the
compounds may exhibit non-anticipated receptor-activation
patterns or lack of selectivity (Michel and Seifert, 2015). In
our previous work, we concluded that the relaxing effect of
(−)-isoprenaline in murine detrusor was mediated via β2-ARs,
because only ICI 118,551 (50 nM) shifted the CRCs for (−)-
isoprenaline to the right, whereas the β1-AR blocker CGP 20712A
(300 nM) and the β3-AR blocker L748,337 (100 nM) were
without effect (Wuest et al., 2009; Propping et al., 2015a). In
contrast, based on experiments with CL 316,243 and with higher
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FIGURE 7 | Effects of various concentrations of the β3-AR-selective blocker L748,337 on CRCs for the tone relaxing effects of CL 316,243 in
KCl-precontracted detrusor strips from WT (A) and β2-AR KO mice (B). Control data (WT, dashed gray lines; β2-AR KO, continuous gray lines) were taken
from Figure 2. (C) Schild plot for determining the pA2 value of L748,337 in β2-AR KO (see Materials and Methods for further details). Please note that no Schild plot
could be obtained for data from WT. Mean values ± SD from n experiments as indicated in parenthesis (number of strips/number of animals).
FIGURE 8 | Concentration-response curves for the relaxing effects of forskolin on KCl-induced contractions in detrusor strips from WT and β2-AR
KO mice. (A) Forskolin effects on tone; effects on spontaneous contractions (B). Mean values ± SD from n experiments as indicated in parenthesis (number of
strips/number of animals).
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concentrations of L748,337 (1–10 µM), other groups reported
that murine detrusor relaxes via activation of β3-ARs (Deba et al.,
2009). Our previous failure to detect a shift in (−)-isoprenaline
CRCs by L748,337 (100 nM) in mouse detrusor may in retrospect
be explained by the recent observation that L748,337 has 10-
100-fold lower affinity to rodent than human β3-ARs (Palea
et al., 2012; van Wieringen et al., 2013). Some of these species
differences in potency have been related to differences in the
binding pocket for L748,337 between human and rodent β3-AR
(Cernecka et al., 2014).
In the present study we employed L748,337 concentrations up
to 10 µM and found significant effects on both (−)-isoprenaline-
and CL 316,243-induced relaxation of detrusor from WT and
β2-AR KO mice. In our previous work, Schild plot analysis
revealed a surmountable antagonism between ICI 118,551 and
(−)-isoprenaline (or adrenaline) in C57Bl6 murine detrusor and
between L748,337 and (−)-isoprenaline (or noradrenaline) in
human detrusor (Wuest et al., 2009; Propping et al., 2013).
However, the mode of antagonism by L748,337 seems to be more
complex in the mouse. As expected, the antagonistic effect of
L748,337 was most consistent in CL-316,243-stimulated detrusor
from β2-AR KO mice, i.e., under conditions when relaxation was
most likely produced by β3-AR activation.
Effects of β-AR Agonists on
Spontaneous Activity
Although, spontaneous activity of detrusor muscle is not
fully understood, increasing evidence suggests that smooth
muscle cells posses intrinsic mechanisms for spontaneous
contractions and that these are synchronized and modulated
by interstitial cells distributed throughout the bladder wall
(Davidson and McCloskey, 2005; Hashitani, 2006; Lagou
et al., 2006). Spontaneous activity in smooth muscle cells and
interstitial cells is associated with intracellular Ca2+ oscillations
but appears to be generated by different mechanism as evidenced
by different pharmacological responses (Johnston et al., 2008).
Here, we observed larger and more spontaneous c contractions
in β2-AR KO than WT strips, and in addition, more spontaneous
activity developed in β2-AR KO strips that were exposed to
the β2-AR antagonist ICI 118,551. While the former finding
could suggest adaptive responses to the chronic absence of β2-
AR mediated signaling pathways, we do not have a plausible
explanation for the latter puzzling finding, which needs to be
verified in future studies in order to exclude random variation
as an underlying cause. Attenuation of spontaneous contractions
by (−)-isoprenaline occurred in the same concentration ranges
in WT and β2-AR KO strips as relaxation of tonic tension, and
the CRC was only shifted to the right by ICI118,551 suggesting
a dominant role for β2-AR in this process. Nevertheless,
the small attenuation of spontaneous activity by CL 316,243
indicates a modulating effect of β3-AR as well. Our findings
do not confirm that suppression of phasic contractions by
(−)-isoprenaline is most sensitive to β1-AR blockers (Gillespie
et al., 2015b), because we did not observe any shift in CRC
with CGP 20712A. Taken together, comparison of the effects
of subtype-selective β-AR agonists and antagonists suggests that
tonic and spontaneous detrusor contractions may be modulated
by different pathways but both β2- and β3-AR appear to be
involved.
Effects of Forskolin
Relaxation of tonic and phasic detrusor contractions after
receptor-independent activation of adenylyl cyclase with
forskolin in WT and β2-AR KO mice were similar between
the two groups. Furthermore, also after forskolin, spontaneous
activity was suppressed less completely than tonic tension.
CONCLUSION
We have reported an example how false extrapolation of drug
affinities for a given receptor subtype from different species can
lead to an incomplete picture. Our novel findings in β2-AR
KO mice suggest that there is a large receptor reserve for β2-
AR so that this β-AR subtype will be activated preferentially
by physiological ligands. Nevertheless β3-AR can also mediate
relaxation and attenuate spontaneous contractions in the absence
of β2-AR, when β2-AR are blocked or when selective β3-AR
agonists are used.
AUTHOR CONTRIBUTIONS
SP: experimental procedure, result analysis, evaluation of results,
writing the manuscript; KL: experimental procedure, result
analysis, evaluation of results, writing the manuscript; MM: result
analysis, evaluation of results, revision of the manuscript; MW:
result analysis, evaluation of results, revision of the manuscript;
UR: result analysis, evaluation of results, writing and revision of
the manuscript.
FUNDING
The study was funded by budget resources of the Department of
Urology and Department of Pharmacology of the Medizinische
Fakultät Carl Gustav Carus, Technische Universität Dresden.
ACKNOWLEDGMENTS
We thank Manja Newe, Judith Müller, Nadine Yurdagül-
Hemmrich, and Gesine Haller for their excellent technical
support.
We acknowledge support by the German Research
Foundation and the Open Access Publication Funds of the TU
Dresden.
Frontiers in Pharmacology | www.frontiersin.org 11 May 2016 | Volume 7 | Article 118
fphar-07-00118 May 5, 2016 Time: 17:58 # 12
Propping et al. Detrusor Relaxation in β2-AR KO Mice
REFERENCES
Andersson, K. E., and Arner, A. (2004). Urinary bladder contraction and
relaxation: physiology and pathophysiology. Physiol. Rev. 84, 935–986. doi:
10.1152/physrev.00038.2003
Blin, N., Nahmias, C., Drumare, M. F., and Strosberg, A. D. (1994).
Mediation of most atypical effects by species homologues of the beta 3-
adrenoceptor. Br. J. Pharmacol. 112, 911–919. doi: 10.1111/j.1476-5381.1994.tb
13167.x
Cernecka, H., Sand, C., and Michel, M. C. (2014). The odd sibling: features
of beta3-adrenoceptor pharmacology. Mol. Pharmacol. 86, 479–484. doi:
10.1124/mol.114.092817
Chapple, C. R., Cardozo, L., Nitti, V. W., Siddiqui, E., and Michel, M. C. (2014).
Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability.
Neurourol. Urodyn. 33, 17–30. doi: 10.1002/nau.22505
Chernogubova, E., Hutchinson, D. S., Nedergaard, J., and Bengtsson, T.
(2005). Alpha1- and beta1-adrenoceptor signaling fully compensates
for beta3-adrenoceptor deficiency in brown adipocyte norepinephrine-
stimulated glucose uptake. Endocrinology 146, 2271–2284. doi: 10.1210/en.20
04-1104
Clouse, A. K., Riedel, E., Hieble, J. P., and Westfall, T. D. (2007). The
effects and selectivity of beta-adrenoceptor agonists in rat myometrium and
urinary bladder. Eur. J. Pharmacol. 573, 184–189. doi: 10.1016/j.ejphar.2007.
06.016
Davidson, R. A., and McCloskey, K. D. (2005). Morphology and localization
of interstitial cells in the guinea pig bladder: structural relationships
with smooth muscle and neurons. J. Urol. 173, 1385–1390. doi:
10.1097/01.ju.0000146272.80848.37
Deba, A., Palea, S., Rouget, C., Westfall, T. D., and Lluel, P. (2009). Involvement
of beta(3)-adrenoceptors in mouse urinary bladder function: role in detrusor
muscle relaxation and micturition reflex. Eur. J. Pharmacol. 618, 76–83. doi:
10.1016/j.ejphar.2009.07.012
Eastham, J., Stephenson, C., Korstanje, K., and Gillespie, J. I. (2015). The expression
of beta3-adrenoceptor and muscarinic type 3 receptor immuno-reactivity in the
major pelvic ganglion of the rat. Naunyn Schmiedebergs Arch. Pharmacol. 388,
695–708. doi: 10.1007/s00210-015-1122-5
Evans, B. A., Papaioannou, M., Hamilton, S., and Summers, R. J. (1999).
Alternative splicing generates two isoforms of the beta3-adrenoceptor which
are differentially expressed in mouse tissues. Br. J. Pharmacol. 127, 1525–1531.
doi: 10.1038/sj.bjp.0702688
Frazier, E. P., Mathy, M. J., Peters, S. L., and Michel, M. C. (2005). Does
cyclic AMP mediate rat urinary bladder relaxation by isoproterenol?
J. Pharmacol. Exp. Ther. 313, 260–267. doi: 10.1124/jpet.104.
077768
Gillespie, J. I., Rouget, C., Palea, S., Granato, C., Birder, L., and Korstanje, C.
(2015a). The characteristics of intrinsic complex micro-contractile activity in
isolated strips of the rat bladder. Naunyn Schmiedebergs Arch. Pharmacol. 388,
709–718. doi: 10.1007/s00210-015-1131-4
Gillespie, J. I., Rouget, C., Palea, S., Granato, C., and Korstanje, C. (2015b).
Beta adrenergic modulation of spontaneous microcontractions and electrical
field-stimulated contractions in isolated strips of rat urinary bladder from
normal animals and animals with partial bladder outflow obstruction. Naunyn
Schmiedebergs Arch. Pharmacol. 388, 719–726. doi: 10.1007/s00210-015-
1136-z
Hashitani, H. (2006). Interaction between interstitial cells and smooth muscles
in the lower urinary tract and penis. J. Physiol. 576, 707–714. doi:
10.1113/jphysiol.2006.116632
Hashitani, H., Brading, A. F., and Suzuki, H. (2004). Correlation between
spontaneous electrical, calcium and mechanical activity in detrusor smooth
muscle of the guinea-pig bladder. Br. J. Pharmacol. 141, 183–193. doi:
10.1038/sj.bjp.0705602
Johnston, L., Carson, C., Lyons, A. D., Davidson, R. A., and McCloskey, K. D.
(2008). Cholinergic-induced Ca2+ signaling in interstitial cells of Cajal from
the guinea pig bladder. Am. J. Physiol. Renal Physiol. 294, F645–F655. doi:
10.1152/ajprenal.00526.2007
Krauwinkel, W., van Dijk, J., Schaddelee, M., Eltink, C., Meijer, J., Strabach, G.,
et al. (2012). Pharmacokinetic properties of mirabegron, a beta3-adrenoceptor
agonist: results from two phase I, randomized, multiple-dose studies in
healthy young and elderly men and women. Clin. Ther. 34, 2144–2160. doi:
10.1016/j.clinthera.2012.09.010
Lagou, M., De Vente, J., Kirkwood, T. B., Hedlund, P., Andersson, K. E., Gillespie,
J. I., et al. (2006). Location of interstitial cells and neurotransmitters in
the mouse bladder. BJU Int. 97, 1332–1337. doi: 10.1111/j.1464-410X.2006.
06203.x
Michel, M. C., and Seifert, R. (2015). Selectivity of pharmacological tools:
implications for use in cell physiology. A review in the theme: cell signaling:
proteins, pathways and mechanisms. Am. J. Physiol. Cell Physiol. 308, C505–
C520. doi: 10.1152/ajpcell.00389.2014
Michel-Reher, M. B., and Michel, M. C. (2015). Regulation of GAPDH
expression by treatment with the beta-adrenoceptor agonist isoprenaline–
is GADPH a suitable loading control in immunoblot experiments? Naunyn
Schmiedebergs Arch. Pharmacol. 388, 1119–1120. doi: 10.1007/s00210-015-
1166-6
Morita, T., Wheeler, M. A., Miyagawa, I., Kondo, S., and Weiss, R. M.
(1986). Effects of forskolin on contractility and cyclic AMP levels in rabbit
detrusor muscle. Tohoku J. Exp. Med. 149, 283–285. doi: 10.1620/tjem.
149.283
Palea, S., Rekik, M., Rouget, C., Camparo, P., Botto, H., Rischmann, P.,
et al. (2012). Fenoterol functionally activates the beta(3)-adrenoceptor in
human urinary bladder, comparison with rat and mouse: implications for
drug discovery. Eur. J. Pharmacol. 690, 202–206. doi: 10.1016/j.ejphar.2012.
06.036
Petkov, G. V. (2014). Central role of the BK channel in urinary bladder
smooth muscle physiology and pathophysiology. Am. J. Physiol.
Regul. Integr. Comp. Physiol. 307, 571–584. doi: 10.1152/ajpregu.001
42.2014
Propping, S., Newe, M., Kaumann, A. J., Wirth, M. P., and Ravens, U.
(2015a). Mucosa of murine detrusor impairs beta2 -adrenoceptor-
mediated relaxation. Neurourol. Urodyn. 34, 592–597. doi: 10.1002/nau.
22627
Propping, S., Newe, M., Lorenz, K., Wirth, M. P., and Ravens, U.
(2015b). Beta-adrenoceptor-mediated relaxation of carbachol-pre-
contracted mouse detrusor. Urol. Int. 95, 92–98. doi: 10.1159/0003
69075
Propping, S., Roedel, M., Wirth, M. P., and Ravens, U. (2015c). Pharmacological
modulation of mucosa-related impairment of beta-adrenoceptor-mediated
relaxation in human detrusor. Urol. Int. 95, 300–308. doi: 10.1159/000
431260
Propping, S., Wuest, M., Eichhorn, B., Wirth, M. P., Kaumann, A. J., and
Ravens, U. (2013). Mucosa of human detrusor impairs contraction and beta-
adrenoceptor-mediated relaxation. BJU Int. 112, 1215–1222. doi: 10.1111/bju.
12267
Schild, H. O. (1947). pA, a new scale for the measurement of drug antagonism.
Br. J. Pharmacol. Chemother. 2, 189–206. doi: 10.1111/j.1476-5381.1947.tb
00336.x
Schmid, E., Neef, S., Berlin, C., Tomasovic, A., Kahlert, K., Nordbeck, P.,
et al. (2015). Cardiac RKIP induces a beneficial beta-adrenoceptor-
dependent positive inotropy. Nat. Med. 21, 1298–1306. doi: 10.1038/
nm.3972
Svalo, J., Nordling, J., Bouchelouche, K., Andersson, K. E., Korstanje, C.,
and Bouchelouche, P. (2013). The novel beta3-adrenoceptor agonist
mirabegron reduces carbachol-induced contractile activity in detrusor
tissue from patients with bladder outflow obstruction with or without detrusor
overactivity. Eur. J. Pharmacol. 699, 101–105. doi: 10.1016/j.ejphar.2012.
11.060
Takeda, H., Matsuzawa, A., Igawa, Y., Yamazaki, Y., Kaidoh, K., Akahane, S.,
et al. (2003). Functional characterization of beta-adrenoceptor subtypes
in the canine and rat lower urinary tract. J. Urol. 170, 654–658. doi:
10.1097/01.ju.0000074622.50255.a8
Tate, K. M., Briend-Sutren, M. M., Emorine, L. J., Delavier-Klutchko, C.,
Marullo, S., and Strosberg, A. D. (1991). Expression of three human
beta-adrenergic-receptor subtypes in transfected Chinese hamster ovary
cells. Eur. J. Biochem. 196, 357–361. doi: 10.1111/j.1432-1033.1991.tb
15824.x
Uchida, H., Shishido, K., Nomiya, M., and Yamaguchi, O. (2005). Involvement of
cyclic AMP-dependent and -independent mechanisms in the relaxation of rat
Frontiers in Pharmacology | www.frontiersin.org 12 May 2016 | Volume 7 | Article 118
fphar-07-00118 May 5, 2016 Time: 17:58 # 13
Propping et al. Detrusor Relaxation in β2-AR KO Mice
detrusor muscle via beta-adrenoceptors. Eur. J. Pharmacol. 518, 195–202. doi:
10.1016/j.ejphar.2005.06.029
van Wieringen, J. P., Michel-Reher, M. B., Hatanaka, T., Ueshima, K., and
Michel, M. C. (2013). The new radioligand [(3)H]-L 748,337 differentially labels
human and rat beta3-adrenoceptors. Eur. J. Pharmacol. 720, 124–130. doi:
10.1016/j.ejphar.2013.10.039
Vidal, M., Wieland, T., Lohse, M. J., and Lorenz, K. (2012). Beta-Adrenergic
receptor stimulation causes cardiac hypertrophy via a Gbetagamma/Erk-
dependent pathway. Cardiovasc. Res. 96, 255–264. doi: 10.1093/cvr/cvs249
Wegener, J. W., Schulla, V., Lee, T. S., Koller, A., Feil, S., Feil, R., et al. (2004). An
essential role of Cav1.2 L-type calcium channel for urinary bladder function.
FASEB J. 18, 1159–1161.
Wuest, M., Eichhorn, B., Grimm, M. O., Wirth, M. P., Ravens, U., and Kaumann,
A. J. (2009). Catecholamines relax detrusor through beta 2-adrenoceptors in
mouse and beta 3-adrenoceptors in man. J. Pharmacol. Exp. Ther. 328, 213–222.
doi: 10.1124/jpet.108.142562
Yamamoto, Y., Mori, A., and Koike, K. (1998). Beta-adrenoceptors in the
detrusor of guinea pig bladder. J. Smooth Muscle Res. 34, 233–242. doi:
10.1540/jsmr.34.233
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Propping, Lorenz, Michel, Wirth and Ravens. This is an
open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in
other forums is permitted, provided the original author(s) or licensor
are credited and that the original publication in this journal is cited,
in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these
terms.
Frontiers in Pharmacology | www.frontiersin.org 13 May 2016 | Volume 7 | Article 118
